Iter-4360dd15-0064-transcript
第 64 轮执行轨迹
→ call search_memory({"limit":10,"query":"4360dd15 NEXT_FOCUS 10 条 PMID 审计表 保留 相关性 强弱 分层"}) → call search_memory({"limit":10,"query":"4360dd15 10-pmid-audit-table PMID 题名 研究类型 保留 理由"})
→ call list_recent({"n":6})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹
→"}, {"title": "Iter-4360dd15-0059-transcript", "tags": "iteration transcript", "modified": "20260424195947000", "preview": "!! 第 59 轮执行轨迹 → call search_memory({\"limit\":10,\"query\":\"4360dd15 NEXT_FOCUS PMID 10 条候选 研究类型 保留 排除 理由\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹
→"}, {"title": "Iter-4360dd15-0059-transcript", "tags": "iteration transcript", "modified": "20260424195947000", "preview": "!! 第 59 轮执行轨迹 → call search_memory({\"limit\":10,\"query\":\"4360dd15 NEXT_FOCUS PMID 10 条候选 研究类型 保留 排除 理由\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) 【tool:search_memory】 {\"ok\": true, \"【tool:list_recent】
{"ok": true, "items": [{"title": "Iter-4360dd15-0063-reflection", "modified": "20260424200443000", "tags": "iteration reflection"}, {"title": "NEXT_FOCUS", "modified": "20260424200443000", "tags": "pinned focus"}, {"title": "先用题名证据锁定研究性质", "modified": "20260424200443000", "tags": "lesson pubmed-verification audit clinical-trials"}, {"title": "Iter-4360dd15-0063-transcript", "modified": "20260424200437000", "tags": "iteration transcript"}, {"title": "Iter-4360dd15-0063-10-pmid-audit-table", "modified": "20260424200432000", "tags": "4360dd15 knowledge fact clinical-trials audit"}, {"title": "Iter-4360dd15-0062-reflection", "modified": "20260424200340000", "tags": "iteration reflection"}]}
→ call read_note({"title":"NEXT_FOCUS"})
→ call read_note({"title":"Iter-4360dd15-0063-10-pmid-audit-table"})
→ call read_note({"title":"Iter-4360dd15-0063-reflection"})
【tool:read_note】
{"ok": true, "title": "NEXT_FOCUS", "tags": "pinned focus", "text": "!! 下轮焦点（来自 mission `4360dd15` · Iter-0063）\n\n把这 10 条已保留 PMID 按与衰老/长寿主问题的相关性强弱做最小分层，并给出每层可验证判据。"}
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0063-10-pmid-audit-table", "tags": "4360dd15 knowledge fact clinical-trials audit", "text": "!! 第 63 轮：10 条 PMID 可审计表\n\n本轮把上一轮已经用 PubMed 题名证据核实为“原始临床研究”的 10 条 PMID，整理为逐条可审计表，统一给出 PMID、题名、研究类型、保留/排除和理由。\n\n| PMID | 题名 | 研究类型 | 处理 | 理由 |\n|---:|---|---|---|---|\n| 33977284 | ''Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.'' | phase 2b/3 randomised trial | 保留 | 明确为随机临床试验，属于原始研究 |\n| 22367193 | ''A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.'' | single-dose controlled study | 保留 | 单次给药对照原始临床研究 |\n| 29408453 | ''A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.'' | randomized controlled trial | 保留 | RCT，直接属于原始临床研究 |\n| 22115710 | ''A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema.'' | randomized dose-escalation study | 保留 | 剂量递增的原始临床试验 |\n| 35040506 | ''mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.'' | randomized double-blind placebo-controlled futility trial + longitudinal analysis | 保留 | 主试验为原始临床试验；longitudinal analysis 为附带分析，不构成排除 |\n| 2552
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0063-reflection", "tags": "iteration reflection", "text": "!! 本轮进展\n已把剩余 10 条 PMID 逐条用题名证据核实并整理成可审计表，确认全部应保留为原始临床研究。\n\n!! 失败 / 盲点\n本轮在表格输出时卡在 Python 终端编码错误上，浪费了时间但未带来新的判别信息。\n\n!! 下轮焦点\n把这 10 条已保留 PMID 按与衰老/长寿主问题的相关性强弱做最小分层，并给出每层可验证判据。\n"}
→ call pubmed_search({"limit":3,"query":"33977284"})
→ call pubmed_search({"limit":3,"query":"29408453"})
→ call pubmed_search({"limit":3,"query":"22367193"})
→ call pubmed_search({"limit":3,"query":"35040506"})
→ call pubmed_search({"limit":3,"query":"18037627"})
→ call pubmed_search({"limit":3,"query":"27613521"})
→ call pubmed_search({"limit":3,"query":"29992557"})
→ call pubmed_search({"limit":3,"query":"24618547"})
→ call pubmed_search({"limit":3,"query":"25525171"})
→ call pubmed_search({"limit":3,"query":"22115710"})
【tool:pubmed_search】
{"ok": true, "query": "33977284", "results": [{"pmid": "33977284", "title": "Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.", "source": "Lancet Healthy Longev", "pubdate": "2021 May", "authors": ["Mannick JB", "Teo G", "Bernardo P", "Quinn D", "Russell K", "Klickstein L", "Marshall W", "Shergill S"], "url": "https://pubmed.ncbi.nlm.nih.gov/33977284/"}]}
【tool:pubmed_search】
{"ok": true, "query": "29408453", "results": [{"pmid": "29408453", "title": "A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.", "source": "Exp Gerontol", "pubdate": "2018 May", "authors": ["Kraig E", "Linehan LA", "Liang H", "Romo TQ", "Liu Q", "Wu Y", "Benavides AD", "Curiel TJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/29408453/"}]}
【tool:pubmed_search】
{"ok": true, "query": "22367193", "results": [{"pmid": "22367193", "title": "A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.", "source": "Cancer Chemother Pharmacol", "pubdate": "2012 Jun", "authors": ["Boni JP", "Leister C", "Hug B", "Burns J", "Sonnichsen D"], "url": "https://pubmed.ncbi.nlm.nih.gov/22367193/"}]}
【tool:pubmed_search】
{"ok": true, "query": "35040506", "results": [{"pmid": "35040506", "title": "mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.", "source": "Mov Disord", "pubdate": "2022 Apr", "authors": ["Palma JA", "Martinez J", "Millar Vernetti P", "Ma T", "Perez MA", "Zhong J", "Qian Y", "Dutta S"], "url": "https://pubmed.ncbi.nlm.nih.gov/35040506/"}]}
【tool:pubmed_search】
{"ok": true, "query": "18037627", "results": [{"pmid": "18037627", "title": "Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.", "source": "Ann Rheum Dis", "pubdate": "2008 Aug", "authors": ["Bruyn GA", "Tate G", "Caeiro F", "Maldonado-Cocco J", "Westhovens R", "Tannenbaum H", "Bell M", "Forre O"], "url": "https://pubmed.ncbi.nlm.nih.gov/18037627/"}]}
【tool:pubmed_search】
{"ok": true, "query": "27613521", "results": [{"pmid": "27613521", "title": "Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.", "source": "Lancet", "pubdate": "2016 Oct 29", "authors": ["French JA", "Lawson JA", "Yapici Z", "Ikeda H", "Polster T", "Nabbout R", "Curatolo P", "de Vries PJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/27613521/"}]}
【tool:pubmed_search】
{"ok": true, "query": "29992557", "results": [{"pmid": "29992557", "title": "Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.", "source": "Int J Cancer", "pubdate": "2019 Feb 15", "authors": ["Tesch H", "Stoetzer O", "Decker T", "Kurbacher CM", "Marmé F", "Schneeweiss A", "Mundhenke C", "Distelrath A"], "url": "https://pubmed.ncbi.nlm.nih.gov/29992557/"}]}
【tool:pubmed_search】
{"ok": true, "query": "24618547", "results": [{"pmid": "24618547", "title": "Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial.", "source": "Pulm Circ", "pubdate": "2013 Sep", "authors": ["Seyfarth HJ", "Hammerschmidt S", "Halank M", "Neuhaus P", "Wirtz HR"], "url": "https://pubmed.ncbi.nlm.nih.gov/24618547/"}]}
【tool:pubmed_search】
{"ok": true, "query": "25525171", "results": [{"pmid": "25525171", "title": "Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.", "source": "Invest Ophthalmol Vis Sci", "pubdate": "2014 Dec 18", "authors": ["Petrou PA", "Cunningham D", "Shimel K", "Harrington M", "Hammel K", "Cukras CA", "Ferris FL", "Chew EY"], "url": "https://pubmed.ncbi.nlm.nih.gov/25525171/"}]}
【tool:pubmed_search】
{"ok": true, "query": "22115710", "results": [{"pmid": "22115710", "title": "A randomized, dose-escalation study of subconjunctival and intravitreal injections of sirolimus in patients with diabetic macular edema.", "source": "Ophthalmology", "pubdate": "2012 Jan", "authors": ["Dugel PU", "Blumenkranz MS", "Haller JA", "Williams GA", "Solley WA", "Kleinman DM", "Naor J"], "url": "https://pubmed.ncbi.nlm.nih.gov/22115710/"}]}
→ call search_memory({"limit":8,"query":"4360dd15 衰老 长寿 相关性 分层 判据 aging relevance criterion"})
【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹
→"}, {"title": "Iter-4360dd15-0037-transcript", "tags": "iteration transcript", "modified": "20260424191347000", "preview": "!! 第 37 轮执行轨迹 → call search_memory({\"limit\":10,\"query\":\"4360dd15 NEXT_FOCUS 剩余 10 条候选 PMID 研究类型 保留 排除 理由 extension follow-up secondary analysis\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15\"}) → call run_python({"code":"pmids = [\n (33977284, 'Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.', 'A'),\n (29408453, 'A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.', 'A'),\n (22367193, 'A)
【tool:run_python】
{"ok": true, "stdout": "", "stderr": "Traceback (most recent call last):\n File \"C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\workspace\\_run_1777061141310.py\", line 24, in <module>\n print(f'Tier {tier}: {criteria[tier]}')\n ~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^\n File \"C:\\Python313\\Lib\\encodings\\cp1252.py\", line 19, in encode\n return codecs.charmap_encode(input,self.errors,encoding_table)[0]\n ~~~~~~~~~~~~~~~~~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^\nUnicodeEncodeError: 'charmap' codec can't encode characters in position 8-12: character maps to <undefined>\n", "returncode": 1}
→ call run_python({"code":"import sys\nsys.stdout.reconfigure(encoding='utf-8')\npmids = [\n (33977284, 'Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.', 'A'),\n (29408453, 'A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performa)
【tool:run_python】
{"ok": true, "stdout": "Tier A :: direct aging target: older adults / biological ageing / age-related functional endpoints\n - 33977284: Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.\n - 29408453: A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.\n\nTier B :: aging-adjacent disease: age-related degeneration with possible longevity-relevant signal\n - 35040506: mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.\n - 25525171: Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.\n\nTier C :: general mTOR clinical trial: indirect relevance to longevity, mostly safety / disease-specific\n - 22367193: A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.\n - 18037627: Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.\n - 27613521: Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo
→ call write_note({"tags":["4360dd15","knowledge","fact","critical-review","stratification"],"text":"!! 第 64 轮：10 条已保留 PMID 的最小相关性分层\n\n本轮不再争论它们是否为原始临床研究，而是按与衰老/长寿主问题的相关性强弱做最小分层。\n\n!! 分层结果\n\n!!! Tier A：直接指向衰老/老年功能表型\n判据：题名直接出现 ''older adults'' / ''biological ageing'' / 年龄相关功能终点（免疫、体能、认知）。\n- PMID 33977284 — ''Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b)
【tool:write_note】
{"ok": true, "path": "C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\wiki\\tiddlers\\Iter-4360dd15-0064-relevance-tiering-10-pmids.tid", "title": "Iter-4360dd15-0064-relevance-tiering-10-pmids"}
【assistant】
已完成第 64 轮：把这 10 条已保留 PMID 做了最小相关性分层，并写入长期记忆。
核心结论很直接：
- Tier A：真正直接指向衰老/老年功能表型，只有 2 条
- Tier B：年龄相关退行性病变，弱相关 2 条
- Tier C：其余 6 条只是一般 mTOR 临床试验，和长寿主问题只有间接关系，不能偷换成长寿证据
最危险的失败点也已明确：**把“mTOR 相关临床试验”整体误当成“长寿证据”**。
这一步如果不严厉切开，后续所有结论都会被适应症噪音污染。
我已把分层判据写成可复核 tiddler，避免继续停留在抽象判断。
<NEXT_FOCUS>只针对 Tier A 的 2 条，抽取它们的主要终点与可量化 aging readout，判断是否真的能作为“衰老干预”证据而不是仅仅“老年人用药”证据。</NEXT_FOCUS>